已发表论文

组蛋白脱乙酰酶在风湿性疾病中的研究进展

 

Authors Liu XM, Yang L, Yang QB

Received 2 November 2023

Accepted for publication 23 January 2024

Published 12 February 2024 Volume 2024:17 Pages 947—955

DOI https://doi.org/10.2147/JIR.S447811

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Tara Strutt

Abstract: Rheumatic disease is a disease which is not yet fully clarified to etiology and also involved in a local pathological injury or systemic disease. With the continuous improvement of clinical medical research in recent years, the development process of rheumatic diseases has been gradually elucidated; with the intensely study of epigenetics, it is realized that environmental changes can affect genetics, among which histone acetylation is one of the essential mechanisms in epigenetics. Histone deacetylases (HDACs) play an important role in regulating gene expression in various biological processes, including differentiation, development, stress response, and injury. HDACs are involved in a variety of physiological processes and are promising drug targets in various pathological conditions, such as cancer, cardiac and neurodegenerative diseases, inflammation, metabolic and immune disorders, and viral and parasitic infections. In this paper, we reviewed the roles of HDACs in rheumatic diseases in terms of their classification and function.

Keywords: histone deacetylase, histone deacetylase inhibitor, rheumatic diseases